TGM4 and autoimmune uveitis: TGP inhibits experimental autoimmune uveitis-induced p38 mitogen-activated protein kinase (p38), extracellular signal regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) phosphorylation, and TGP mediates mouse autoimmune uveitis by inhibiting the MAPK signaling pathway (Huang et al., 2018).